Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndoNom Medtech is a specialized medical device company headquartered in Shanghai, China, focusing on the field of minimally invasive vascular intervention. The company develops and manufactures a comprehensive range of products for aortic, peripheral, and venous diseases, including advanced stent grafts and balloon catheters. Its flagship products are designed to treat complex conditions such as abdominal and thoracic aortic aneurysms with high precision and safety. EndoNom has successfully secured significant venture capital funding from top-tier investors like Sequoia China and GL Capital to support its R&D and market expansion. The company is positioned as a rising leader in the Chinese interventional medtech sector, aiming to compete with global players through innovation and localized manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EndoNom Medtech.